Laurie J. Hall Trustee’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-110
Closed -$5K 193
2024
Q4
$5K Hold
110
﹤0.01% 240
2024
Q3
$7K Hold
110
﹤0.01% 246
2024
Q2
$13K Hold
110
﹤0.01% 225
2024
Q1
$12K Hold
110
﹤0.01% 230
2023
Q4
$11K Hold
110
﹤0.01% 231
2023
Q3
$11K Hold
110
﹤0.01% 231
2023
Q2
$13K Hold
110
0.01% 227
2023
Q1
$17K Hold
110
0.01% 219
2022
Q4
$20K Hold
110
0.01% 211
2022
Q3
$13K Hold
110
0.01% 234
2022
Q2
$16K Hold
110
0.01% 238
2022
Q1
$19K Hold
110
0.01% 243
2021
Q4
$28K Buy
+110
New +$32.2K 0.01% 233

Other funds holding MRNA

Laurie J. Hall Trustee's MRNA Position: Q1 2025 in Review

Laurie J. Hall Trustee sold out of Moderna (MRNA) in Q1 2025, closing a stake of 110 shares — an estimated $5K sold.

Laurie J. Hall Trustee first reported a position in MRNA in Q4 2021 and held it in 13 quarters. The position peaked at $28K in Q4 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Laurie J. Hall Trustee reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 110 Moderna shares in Q1 2025, an estimated $5K.
  • Laurie J. Hall Trustee first reported a position in Moderna in Q4 2021 and held it in 13 quarters.
  • Laurie J. Hall Trustee's Moderna position peaked at $28K in Q4 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2025, filed 15 May 2025.